Clinical Trial

Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy

Name: Immediate Postoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy — clinical trial record (NCT06899529)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Postop IVA

Recruiting

View on ClinicalTrials.gov →

Summary

Patients undergoing surgery for complications related to diabetes will be recruited.

Trial Details

NCT Number	NCT06899529
Lead Sponsor	Christian Ophthalmic Surgery Expedition Network
Conditions	Proliferative Diabetic Retinopathy - High Risk
Enrollment	150 participants
Start Date	2025-03-20
Primary Completion	2027-03-20 (estimated)
Study Completion	2027-05-20 (estimated)
Updated on ClinicalTrials.gov	2025-03-28